
Proceedings Paper
Diagnosing urothelial carcinoma through multiple spectroscopic techniquesFormat | Member Price | Non-Member Price |
---|---|---|
$17.00 | $21.00 |
Paper Abstract
Urothelial carcinoma (UC) is the most common type of bladder cancer, and its treatment depends from both tumour invasiveness (stage) and aggressiveness (grade). The gold standard for detecting UC is white-light cystoscopy, followed by tissue biopsy and histopathological examination; however, such process is invasive, time-consuming, operatordependent and prone to sampling errors. In this framework, optical spectroscopy techniques can provide a fast, label-free and non-invasive tool for improving diagnosis. Thus, we combined auto-fluorescence, diffuse reflectance and Raman spectroscopy in a compact and transportable setup based on an optical fibre-bundle probe. This experimental setup was used for studying fresh biopsies of urothelial tumour (129 samples) and healthy bladder (40 samples) collected from 78 patients undergoing Transurethral Resection of Bladder Tumours (TURBT). The recorded data were analysed using Principal Component Analysis (PCA) and Linear Discriminant Analysis (LDA) for obtaining an automated classification of the examined samples based on the intrinsic spectral information provided by all three techniques. We found that healthy and diseased tissues showed significant spectral differences for each technique, resulting in high accuracy (up to 90%) from PCA-LDA routines. While fluorescence spectroscopy seems sensitive enough for detecting UC, we found that a multimodal approach is crucial for obtaining high discriminating capability (<80%) in grading and staging tumour biopsies. In conclusion, the presented strategy generates results similar to gold standard histology, but in a fast and labelfree way, offering the potential for endoscopic in vivo applications.
Paper Details
Date Published: 19 February 2020
PDF: 3 pages
Proc. SPIE 11212, Therapeutics and Diagnostics in Urology 2020, 1121207 (19 February 2020); doi: 10.1117/12.2545987
Published in SPIE Proceedings Vol. 11212:
Therapeutics and Diagnostics in Urology 2020
Hyun Wook Kang, Editor(s)
PDF: 3 pages
Proc. SPIE 11212, Therapeutics and Diagnostics in Urology 2020, 1121207 (19 February 2020); doi: 10.1117/12.2545987
Show Author Affiliations
Enrico Baria, Istituto Nazionale di Ottica (Italy)
Univ. degli Studi di Firenze (Italy)
Simone Morselli, Univ. degli Studi di Firenze (Italy)
Andrea Liaci, Univ. degli Studi di Firenze (Italy)
Mauro Gacci, Univ. degli Studi di Firenze (Italy)
Univ. degli Studi di Firenze (Italy)
Simone Morselli, Univ. degli Studi di Firenze (Italy)
Andrea Liaci, Univ. degli Studi di Firenze (Italy)
Mauro Gacci, Univ. degli Studi di Firenze (Italy)
Sergio Serni, Univ. degli Studi di Firenze (Italy)
Marco Carini, Univ. degli Studi di Firenze (Italy)
Riccardo Cicchi, Istituto Nazionale di Ottica (Italy)
Univ. degli Studi di Firenze (Italy)
Francesco S. Pavone, Istituto Nazionale di Ottica (Italy)
Univ. degli Studi di Firenze (Italy)
Marco Carini, Univ. degli Studi di Firenze (Italy)
Riccardo Cicchi, Istituto Nazionale di Ottica (Italy)
Univ. degli Studi di Firenze (Italy)
Francesco S. Pavone, Istituto Nazionale di Ottica (Italy)
Univ. degli Studi di Firenze (Italy)
Published in SPIE Proceedings Vol. 11212:
Therapeutics and Diagnostics in Urology 2020
Hyun Wook Kang, Editor(s)
© SPIE. Terms of Use
